Prearrest administration of low-molecular-weight heparin in porcine cardiac arrest: Hemodynamic effects and resuscitability

Critical Care Medicine

Volumn 36, Issue 3, 2008, Pages 881-886

  Pytte, Morten ^a   Bendz, Bjørn ^b   Kramer Johansen, Jo ^a,c   Eriksen, Morten ^a   Strømme, Tævje A ^a   Eilevstjønn, Joar ^d   Brosstad, Frank ^b   Sunde, Kjetil ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c DEPARTMENT OF RESEARCH AND DEVELOPMENT   (Norway)

^d Laerdal Medical   (Norway)

Author keywords

Advanced cardiac life support; Animal; Anticoagulants; Cardiopulmonary resuscitation; Heart arrest; Ventricular fi brillation

Indexed keywords

ADRENALIN; BLOOD CLOTTING FACTOR 10A; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; OXYGEN; PLACEBO; SODIUM CHLORIDE; THROMBIN ANTITHROMBIN COMPLEX; FIBRINOLYTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; ARTIFICIAL VENTILATION; BLOOD CLOTTING; BLOOD SAMPLING; BRAIN BLOOD FLOW; CIRCULATION; CONTROLLED STUDY; DEFIBRILLATION; ELECTROCARDIOGRAM; FEMALE; HEART ARREST; HEART HEMODYNAMICS; HEART VENTRICLE FIBRILLATION; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SWINE; ANIMAL; DRUG EFFECT; HEMODYNAMICS;

ANIMALS; CARDIOPULMONARY RESUSCITATION; FEMALE; FIBRINOLYTIC AGENTS; HEART ARREST; HEMODYNAMICS; HEPARIN, LOW-MOLECULAR-WEIGHT; SWINE;

EID: 44449166235     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0B013E318164E781     Document Type: Article

References (33)

1. Bottiger BW, Motsch J, Bohrer H, et al: Activation of blood coagulation after cardiac arrest is not balanced adequately by activation of endogenous fibrinolysis. Circulation 1995;92:2572-2578
2. Gando S, Kameue T, Nanzaki S, et al: Massive fibrin formation with consecutive impairment of fibrinolysis in patients with out-of-hospital cardiac arrest. Thromb Haemost 1997;77:278-282
3. Hartveit F, Halleraker B: Intravascular changes in kidneys and lungs after external cardiac massage: A preliminary report. J Pathol 1970;102:54-58
4. Adrie C, Monchi M, Laurent I, et al: Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: Implication of the protein C anticoagulant pathway. J Am Coll Cardiol 2005;46:21-28
5. Gaszynski W: The use of protease inhibitor (trasylol) and heparin in cardiorespiratory resuscitation. I. Studies of the blood clotting system. Anaesth Resusc Intensive Ther 1975;3:125-134
6. Crowell JW, Sharpe GP, Lambright RL, et al: The mechanism of death after resuscitation following acute circulatory failure. Surgery 1955;38:696-702
7. Johansson J, Ridefelt P, Basu S, et al: Antithrombin administration during experimental cardiopulmonary resuscitation. Resuscitation 2004;62:71-78 (Pubitemid 38916594)
8. Gando S, Nanzaki S, Morimoto Y, et al: Tissue factor and tissue factor pathway inhibitor levels during and after cardiopulmonary resuscitation. Thromb Res 1999;96:107-113
9. McKay DG, Latour JG, Parrish MH: Activation of Hageman factor by alpha-adrenergic stimulation. Thromb Diath Haemorrh 1970;23:417-422
10. Davies MJ, Thomas A: Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N Engl J Med 1984;310:1137-1140
11. Holmes HR, Babbs CF, Voorhees WD, et al: Influence of adrenergic drugs upon vital organ perfusion during CPR. Crit Care Med 1980;8:137-140
12. Wenzel V, Lindner KH, Krismer AC, et al: Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation 1999;99:1379-1384
13. Halperin HR, Tsitlik JE, Guerci AD, et al: Determinants of blood flow to vital organs during cardiopulmonary resuscitation in dogs. Circulation 1986;73:539-550
14. Loeckinger A, Kleinsasser A, Wenzel V, et al: Pulmonary gas exchange after cardiopulmonary resuscitation with either vasopressin or epinephrine. Crit Care Med 2002;30:2059-2062
15. Voelckel WG, Lurie KG, McKnite S, et al: Effects of epinephrine and vasopressin in a piglet model of prolonged ventricular fibrillation and cardiopulmonary resuscitation. Crit Care Med 2002;30:957-962
16. Yannopoulos D, Aufderheide TP, Gabrielli A, et al: Clinical and hemodynamic comparison of 15:2 and 30:2 compression-to-ventilation ratios for cardiopulmonary resuscitation. Crit Care Med 2006;34:1444-1449
17. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2005;112: IV58-IV66
18. Muir JK, Boerschel M, Ellis EF: Continuous monitoring of posttraumatic cerebral blood flow using laser-Doppler flowmetry. J Neurotrauma 1992;9:355-362
19. Rubertsson S, Karlsten R: Increased cortical cerebral blood flow with LUCAS: A new device for mechanical chest compressions compared to standard external compressions during experimental cardiopulmonary resuscitation. Resuscitation 2005;65:357-363
20. Dorph E, Wik L, Stromme TA, et al: Oxygen delivery and return of spontaneous circulation with ventilation:compression ratio 2:30 versus chest compressions only CPR in pigs. Resuscitation 2004;60:309-318
21. Kirkeby OJ, Rise IR, Nordsletten L, et al: Cerebral blood flow measured with intracerebral laser-Doppler flow probes and radioactive microspheres. J Appl Physiol 1995;79:1479-1486
22. Neurauter A, Eftestol T, Kramer-Johansen J, et al: Prediction of countershock success using single features from multiple ventricular fibrillation frequency bands and feature combinations using neural networks. Resuscitation 2007;73:253-263
23. Pytte M, Kramer-Johansen J, Eilevstjonn J, et al: Haemodynamic effects of adrenaline (epinephrine) depend on chest compression quality during cardiopulmonary resuscitation in pigs. Resuscitation 2006;71:369-378
24. Ravanat C, Freund M, Dol F, et al: Crossreactivity of human molecular markers for detection of prethrombotic states in various animal species. Blood Coagul Fibrinolysis 1995;6:446-455
25. Smith BS, Gandhi PJ: Pharmacokinetics and pharmacodynamics of low-molecular-weight heparins and glycoprotein IIb/IIIa receptor antagonists in renal failure. J Thromb Thrombolysis 2001;11:39-48
26. Weitz JI: Low-molecular-weight heparins. N Engl J Med 1997;337:688-698
27. Hekmatpanah J: Cerebral blood flow dynamics in hypotension and cardiac arrest. Neurology 1973;23:174-180
28. Fisher EG, Ames A: III: Studies on mechanisms of impairment of cerebral circulation following ischemia: Effect of hemodilution and perfusion pressure. Stroke 1972;3:538-542
29. Safar P: Amelioration of brain damage after 12 minutes' cardiac arrest in dogs. Arch Neurol 1976;33:91-95
30. Zhang Z, Zhang Q, Cheng Y, et al: Antagonistic effects of ultra-low-molecular-weight heparin against cerebral ischemia/reperfusion injury in rats. Pharmacol Res 2007;56:350-355
31. Bottiger BW, Bode C, Kern S, et al: Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: A prospective clinical trial. Lancet 2001;357:1583-1585
32. Lederer W, Lichtenberger C, Pechlaner C, et al: Recombinant tissue plasminogen activator during cardiopulmonary resuscitation in 108 patients with out-of-hospital cardiac arrest. Resuscitation 2001;50:71-76
33. Boettiger BW. Hot Lines and Clinical Trial Updates. http://www.escardio. org/knowledge/congresses/CongressReports/hotlinesandctus/709011-Boettiger.htm. Accessed August 3, 2007